Fibroblast Growth Factor Type 2 (FGF2) Administration Attenuated the Clinical Manifestations of Preeclampsia in a Murine Model Induced by L-NAME.

导出 LinkOut

翻译打印收藏纠错

第一作者： Margarita L,Martinez-Fierro

第一单位： Molecular Medicine Laboratory, Unidad Academica de Medicina Humana y C.S, Universidad Autonoma de Zacatecas, Zacatecas, Mexico.

作者： Margarita L,Martinez-Fierro ^[1] ; Gloria Patricia,Hernadez-Delgadillo ^[2] ; Jose Feliciano,Flores-Mendoza ^[1] ; Claudia Daniela,Alvarez-Zuñiga ^[1] ; Martha Lizeth,Diaz-Lozano ^[1] ; Ivan,Delgado-Enciso ^[3] ; Viktor Javier,Romero-Diaz ^[4] ; Adrian,Lopez-Saucedo ^[5] ; Iram Pablo,Rodriguez-Sanchez ^[6] ; Ivan Alberto,Marino-Martinez ^[7] ; Idalia,Garza-Veloz ^[1]

作者单位： Molecular Medicine Laboratory, Unidad Academica de Medicina Humana y C.S, Universidad Autonoma de Zacatecas, Zacatecas, Mexico. ^[1] Laboratorio de Investigacion en Farmacologia, Unidad Academica de Ciencias Quimicas, Universidad Autonoma de Zacatecas, Zacatecas, Mexico. ^[2] Department of Molecular Medicine, School of Medicine, University of Colima, Colima, Mexico. ^[3] Department of Histology, Universidad Autonoma de Nuevo Leon, Facultad de Medicina, Monterrey, Mexico. ^[4] Health Sciences Area, Universidad Autonoma de Zacatecas, Zacatecas, Mexico. ^[5] Molecular and Structural Physiology Laboratory, School of Biological Sciences, Autonomous University of Nuevo Leon, Monterrey, Mexico. ^[6] Departamento de Patologia, Facultad de Medicina, Autonomous University of Nuevo Leon, Monterrey, Mexico. ^[7]

关键词 FGF2 L-NAME angiogenesis preeclampsia pregnancy hypertensive disorders rat model

DOI 10.3389/fphar.2021.663044

PMID 33959027

发布时间 2021-05-08

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Frontiers in pharmacology

2021年12卷

663044页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Fibroblast Growth Factor Type 2 (FGF2) Administration Attenuated the Clinical Manifestations of Preeclampsia in a Murine Model Induced by L-NAME.

Frontiers in pharmacology

相似文献

Frontiers in pharmacology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Fibroblast Growth Factor Type 2 (FGF2) Administration Attenuated the Clinical Manifestations of Preeclampsia in a Murine Model Induced by L-NAME.

Frontiers in pharmacology

相似文献

Frontiers in pharmacology

相关期刊

检索历史清除